story of the week
Durvalumab in Combination With BCG Therapy or EBRT in Patients With BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Eur Urol 2023 Jan 28;[EPub Ahead of Print], NM Hahn, MA O'Donnell, JA Efstathiou, M Zahurak, GL Rosner, J Smith, MR Kates, TJ Bivalacqua, PT Tran, DY Song, AS Baras, A Matoso, W Choi, KN Smith, DM Pardoll, L Marchionni, B McGuire, M Grace Phelan, BA Johnson, T O'Neal, DJ McConkey, TL Rose, M Bjurlin, EA Lim, CG Drake, JM McKiernan, I Deutsch, CB Anderson, DL Lamm, DM Geynisman, ER Plimack, MA Hallman, EM Horwitz, E Al-Saleem, DYT Chen, RE Greenberg, A Kutikov, G Guo, TA Masterson, N Adra, HZ KaimakliotisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.